VPS53 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.66566760384512E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.29070145869082E-12 |
Normal-vs-Stage2 |
1.19437792989174E-12 |
Normal-vs-Stage3 |
3.33066907387547E-16 |
Normal-vs-Stage4 |
1.64679381242649E-12 |
Stage1-vs-Stage2 |
8.013900E-02 |
Stage1-vs-Stage3 |
7.591200E-04 |
Stage1-vs-Stage4 |
1.702230E-02 |
Stage2-vs-Stage3 |
4.694400E-01 |
Stage2-vs-Stage4 |
7.642200E-01 |
Stage3-vs-Stage4 |
7.043800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.33146835171283E-14 |
Normal-vs-AfricanAmerican |
7.26140003681763E-09 |
Normal-vs-Asian |
6.612000E-02 |
Caucasian-vs-AfricanAmerican |
5.362800E-01 |
Caucasian-vs-Asian |
8.762100E-02 |
AfricanAmerican-vs-Asian |
2.659800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62836411021772E-12 |
Normal-vs-Female |
1.42520439894156E-11 |
Male-vs-Female |
4.975800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.26999999978162E-07 |
Normal-vs-Age(41-60Yrs) |
9.27702359376781E-13 |
Normal-vs-Age(61-80Yrs) |
1.54321000422897E-14 |
Normal-vs-Age(81-100Yrs) |
1.40150000493833E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.351600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.521400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.526200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.308760E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.447600E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.834400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.263610E-01 |
Normal-vs-Grade 2 |
2.87281309852006E-12 |
Normal-vs-Grade 3 |
1.63025148935958E-12 |
Normal-vs-Grade 4 |
1.37667655053519E-14 |
Grade 1-vs-Grade 2 |
6.363500E-03 |
Grade 1-vs-Grade 3 |
4.751900E-04 |
Grade 1-vs-Grade 4 |
4.568600E-04 |
Grade 2-vs-Grade 3 |
5.102300E-02 |
Grade 2-vs-Grade 4 |
3.777800E-02 |
Grade 3-vs-Grade 4 |
4.884200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.15125703309604E-12 |
Normal-vs-ccB subtype |
1.86306525762348E-12 |
ccA subtype-vs-ccB subtype |
2.683000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.34097202628436E-13 |
Normal-vs-N1 |
6.409500E-04 |
N0-vs-N1 |
6.233000E-01 |
|
|